Peli BioThermal Announces Strategic Partnership with Polar Group in Brazil
Published: 25 Mar 2026
Author: Precedence Research
On March 3, 2026, Peli BioThermal announced a strategic partnership with Polar Group to expand access to temperature-controlled packaging solutions across Brazil. The collaboration aims to strengthen cold chain capabilities in one of the world’s fastest-growing pharmaceutical and healthcare markets. Under this agreement, Polar Group will handle sales and leasing support for Peli BioThermal’s range of reusable and single-use shipping solutions. This will allow pharmaceutical, biotechnology, and healthcare organizations in Brazil to more easily access reliable temperature-controlled packaging, supported by local expertise and service capabilities.
Brazil’s pharmaceutical sector is growing rapidly, particularly with the increasing use of biologics, advanced therapies, and other temperature-sensitive medicines. Ensuring that these products remain within required temperature ranges during transport is critical to maintaining their safety and effectiveness. This partnership is expected to address that need by improving access to proven cold chain technologies and strengthening logistics infrastructure in the region. Peli BioThermal’s CEO, Sam Herbert, highlighted the importance of Brazil as a key market and emphasized the value of working with a partner that understands local requirements. He noted that Polar Group’s technical expertise and strong regional presence make it well-suited to support the safe delivery of temperature-sensitive therapies.
Similarly, Paulo Vitor de Andrade stated that the partnership represents a significant step forward for Brazil’s cold chain sector. He explained that integrating advanced, internationally aligned technologies will help elevate standards in the market while supporting the company’s growth and innovation strategy across Latin America. The combined portfolios of both companies cover a wide range of temperature requirements, including ambient, refrigerated, frozen, and deep-frozen conditions. These solutions are commonly used in transporting commercial pharmaceuticals, clinical trial materials, and advanced therapies that require strict temperature control.
In addition to improving product availability, the partnership is expected to support regulatory compliance and operational efficiency for companies operating in Brazil. By offering dependable access to high-performance shipping systems, Polar Group can help customers maintain consistency in their supply chains.
Overall, this collaboration marks an important step in enhancing Brazil’s pharmaceutical logistics capabilities, ensuring safer and more reliable delivery of temperature-sensitive medicines to patients across the country.
We focus exclusively on this industry and provide insights that help you make better decisions. Get in touch to learn more@ https://www.precedenceresearch.com/pharmaceutical-temperature-controlled-packaging-solutions-market